| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wang AY et al. | Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. | 2014 | J. Am. Soc. Nephrol. | pmid:24052631 |
| Eren Z et al. | Effects of paricalcitol and aliskiren combination therapy on experimental diabetic nephropathy model in rats. | 2014 | Kidney Blood Press. Res. | pmid:25532067 |
| Duffy MM et al. | Mesenchymal stem cells and a vitamin D receptor agonist additively suppress T helper 17 cells and the related inflammatory response in the kidney. | 2014 | Am. J. Physiol. Renal Physiol. | pmid:25339699 |
| Sahin I et al. | Paricalcitol counteracts the increased contrast induced nephropathy caused by renin-angiotensin-aldosterone system blockade therapy in a rat model. | 2014 | Eur Rev Med Pharmacol Sci | pmid:25339484 |
| Ritter C et al. | Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats. | 2014 | Kidney Blood Press. Res. | pmid:25300759 |
| González-Mateo GT et al. | Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production. | 2014 | PLoS ONE | pmid:25279459 |
| Choudhury S et al. | Abnormal calcium handling and exaggerated cardiac dysfunction in mice with defective vitamin d signaling. | 2014 | PLoS ONE | pmid:25268137 |
| Zoccali C et al. | Paricalcitol and endothelial function in chronic kidney disease trial. | 2014 | Hypertension | pmid:25259743 |
| Hansen D et al. | The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study. | 2014 | BMC Nephrol | pmid:25112372 |
| Suarez-Martinez E et al. | Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice. | 2014 | Ther Adv Cardiovasc Dis | pmid:25037058 |
| Carpenter TO et al. | Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study. | 2014 | J. Clin. Endocrinol. Metab. | pmid:25029424 |
| Coyne DW et al. | A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD. | 2014 | Clin J Am Soc Nephrol | pmid:24970869 |
| Gueutin V et al. | [Diabetic nephropathy: emerging treatments]. | 2014 | Nephrol. Ther. | pmid:24938412 |
| Guo C et al. | Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids. | 2014 | Mol Nutr Food Res | pmid:24039193 |
| Moe SM and Thadhani R | What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials? | 2013 | Curr. Opin. Nephrol. Hypertens. | pmid:24100218 |
| Havakuk O et al. | Effect of vitamin D analogues on acute cardiorenal syndrome: a laboratory rat model. | 2013 | Isr. Med. Assoc. J. | pmid:24511650 |
| de Boer IH et al. | Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease. | 2013 | Kidney Int. | pmid:22913981 |
| Azak A et al. | Effect of novel vitamin D receptor activator paricalcitol on renal ischaemia/reperfusion injury in rats. | 2013 | Ann R Coll Surg Engl | pmid:24112495 |
| Chen B et al. | Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects. | 2013 | Bioorg. Med. Chem. Lett. | pmid:24035340 |
| Pérez-Gómez MV et al. | Vitamin D and proteinuria: a critical review of molecular bases and clinical experience. | 2013 | Nefrologia | pmid:24089164 |
Paricalcitol
Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.
Cross Reference
Introduction
To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Paricalcitol?
Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Paricalcitol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Paricalcitol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Paricalcitol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What genes are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Paricalcitol?
There are no associated biomedical information in the current reference collection.